MediBeacon

Saint Louis, MO · Founded 2011 · Privately Held (backing)

Developer of fluorescent tracer-agent-based systems designed to help provide a vital and actionable measurement of organ function. MediBeacon is based in Saint Louis, MO and was founded in 2011. Its last reported valuation was $300 million in Sep 2019. It has raised $111 million across 10 recorded rounds; the latest was a $16.1 million early-stage round in Aug 2023.

Last reported valuation
$300.0M
Oct 2026
Priced at
—
Total raised
$110.6M
Last round
Early Stage VC
Aug 2023

Who backs MediBeacon?

16 investors
InvestorType
Gates FoundationOther
Jump CapitalVenture capital
BioGenerator VenturesVenture capital
Missouri Technology CorporationVenture capital
NEXT Mannheim—
Accelerate St. Louis—
Helix Funds—
Holton Capital Group—
Huadong Medicine Company—
Innovate (Financial Services Company)—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MediBeacon investors

16 investors are on record for MediBeacon, including Gates Foundation, Jump Capital, BioGenerator Ventures and Missouri Technology Corporation. The early-stage round in Aug 2023 drew 38 investors.

Free account
More of MediBeacon with a free account
  • ·The complete investor list: 16 names
  • ·Watch MediBeacon: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like MediBeacon. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View